ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,370, issued on May 26, was assigned to Institute For Cancer Research (Philadelphia).
"Combination therapy for treatment of cancer" was invented by James S. Duncan (Philadelphia).
According to the abstract* released by the U.S. Patent & Trademark Office: "Pharmaceutical compositions comprising: one or more bromodomain and extra terminal domain (BET) proteolysis targeting chimera (PROTAC) (BET-PROTAC) therapeutic agents or one or more cyclin-dependent kinase 9 (CDK9) PROTAC (CDK9-PROTAC) therapeutic agents; and one or more kinase inhibitors, one or more KRAS inhibitors, or one or more autophagy inhibitors; and methods of treating cancer in a human patient by administering such pharm...